MORRISTOWN, N.J., Sept. 05, 2023 (GLOBE NEWSWIRE) — Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat rare and serious liver diseases, today announced that Jerry Durso, President and Chief Executive Officer of Intercept, and Andrew Saik, Chief Financial Officer…Read More
Intercept Pharmaceuticals to Conduct Fireside Chats and OneonOne Meetings at Upcoming Investor Conferences
